Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 13
2003 11
2004 16
2005 25
2006 24
2007 20
2008 20
2009 35
2010 51
2011 43
2012 50
2013 46
2014 49
2015 47
2016 49
2017 49
2018 58
2019 53
2020 61
2021 76
2022 56
2023 76
2024 29

Text availability

Article attribute

Article type

Publication date

Search Results

840 results

Results by year

Filters applied: . Clear all
Page 1
Epidemiological and Clinical Aspects of Cutaneous and Mucosal Leishmaniases in Portugal: Retrospective Analysis of Cases Diagnosed in Public Hospitals and Reported in the Literature between 2010 and 2020.
Rocha R, Conceição C, Gonçalves L, Carvalho AC, Maia A, Martins A, Carujo A, Maio A, Forra C, Melita C, Couto D, Fernandes D, Pereira D, Leal E, Sarmento H, Sousa I, Gonçalves JP, Marinho J, Vasconcelos J, Cunha J, Rodrigues J, Silva JM, Caley L, Malheiro L, Santos L, Garcia M, Cunha M, Lima M, Andrade MM, Marques M, Alpalhão M, Silva M, Ferraz R, Soares R, Fernandes S, Llobet S, Cruz S, Guimarães T, Branco T, Robalo-Nunes T, Almeida V, Maia C. Rocha R, et al. Among authors: lima m. Microorganisms. 2024 Apr 18;12(4):819. doi: 10.3390/microorganisms12040819. Microorganisms. 2024. PMID: 38674763 Free PMC article.
Efficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA): a randomized, placebo-controlled, phase 2/3 trial.
Lobo SM, Plantefève G, Nair G, Joaquim Cavalcante A, Franzin de Moraes N, Nunes E, Barnum O, Berdun Stadnik CM, Lima MP, Lins M, Hajjar LA, Lipinski C, Islam S, Ramos F, Simon T, Martinot JB, Guimard T, Desclaux A, Lioger B, Neuenschwander FC, DeSouza Paolino B, Amin A, Acosta SA, Dilling DF, Cartagena E, Snyder B, Devaud E, Barreto Berselli Marinho AK, Tanni S, Milhomem Beato PM, De Wit S, Selvan V, Gray J, Fernandez R, Pourcher V, Maddox L, Kay R, Azbekyan A, Chabane M, Tourette C, Esmeraldino LE, Dilda PJ, Lafont R, Mariani J, Camelo S, Rabut S, Agus S, Veillet S, Dioh W, van Maanen R, Morelot-Panzini C. Lobo SM, et al. Among authors: lima mp. EClinicalMedicine. 2024 Jan 3;68:102383. doi: 10.1016/j.eclinm.2023.102383. eCollection 2024 Feb. EClinicalMedicine. 2024. PMID: 38545090 Free PMC article.
The Synthetic Peptide LyeTx I mn∆K, Derived from Lycosa erythrognatha Spider Toxin, Is Active against Methicillin-Resistant Staphylococcus aureus (MRSA) In Vitro and In Vivo.
Vieira APGC, de Souza AN, Lima WG, Brito JCM, Simião DC, Gonçalves LVR, Cordeiro LPB, de Oliveira Scoaris D, Fernandes SOA, Resende JM, Bechinger B, Verly RM, de Lima ME. Vieira APGC, et al. Among authors: de lima me. Antibiotics (Basel). 2024 Mar 8;13(3):248. doi: 10.3390/antibiotics13030248. Antibiotics (Basel). 2024. PMID: 38534683 Free PMC article.
840 results